Australia's INOVIQ hits 2-week low as annual loss widens
** Shares of INOVIQ IIQ.AX fall as much as 2.5% to A$0.390, marking their lowest since Aug 6 ** Last down 1.3% ** Cancer therapy co FY net loss after tax widens to A$6.9 million ($4.43 million) from A$6.6 million ** On a weekly basis, shares down nearly 7%, set for worst since week-ending June 20 ** Stock down 23.3% YTD, including moves in current session ($1 = 1.5584 Australian dollars) (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Recent news on Inoviq
See all newsBrief: Inoviq Posts FY26 Net Loss After Tax A$7.5 Million
Brief: INOVIQ Requests Trading Halt
Brief: INOVIQ Says Peter Gunzburg Elected To Role Of Chairman
Brief: Inoviq Says Chairman David Williams To Step Down At Year-End
Australia's INOVIQ slips to 2-1/2-month low on $6.2 million discounted placement